Home » Stocks » PHIC

Population Health Investment Co., Inc. (PHIC)

Population Health Investment currently trades with the ticker symbol PHICU
Stock Price: $10.19 USD 0.02 (0.20%)
Updated November 30, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 152.85M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 18.75M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $10.19
Previous Close $10.17
Change ($) 0.02
Change (%) 0.20%
Day's Open -
Day's Range 10.19 - 10.19
Day's Volume 0
52-Week Range 10.07 - 10.19

More Stats

Market Cap 152.85M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 18.75M
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name Population Health Investment Co., Inc.
Country United States
CEO Clive Meanwell

Stock Information

Ticker Symbol PHIC
Stock Exchange NASDAQ
Industry Blank Checks / SPAC
Unique Identifier NASDAQ: PHIC
IPO Date November 18, 2020


Population Health Investment Co., Inc. is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While we may pursue an initial business combination in any industry, sector, or geographic region, we will focus on companies in the healthcare industry, and in particular the therapeutics sector, in the United States and other developed countries. We intend to capitalize on the unique mix of experience and highly-complementary capabilities of our co-founders, Clive Meanwell and Ian Read, as well as our management team, in leading, operating and strategically positioning global companies in that sector, as well as investing and managing capital, structuring transactions and building businesses. We believe that our industry knowledge and operating experience, in addition to our co-founders’ reputations and strong track record of creating shareholder value, make us a partner of choice for owners and management teams of highly attractive private companies.